PRF Technologies Ltd. (PRFX)
NasdaqCM: PRFX
· Precio en tiempo real · USD
1.03
-0.17 (-14.17%)
Al cierre: Aug 14, 2026, 3:59 PM
1.01
-1.94%
Fuera de horario: 7:55 PM
PRF Technologies Ltd. (PRFX) Stock Price, Analysis & Data
-14.17% (1D)
| Precio de compra | 0.76 |
| Capitalización de mercado | 3.13M |
| Ingresos (TTM) | 17K |
| Beneficio neto (TTM) | -4.84M |
| Beta | 1.04 |
| EPS (TTM) | -7.47 |
| Ratio PER (TTM) | n/a |
| Adelante PE | -0.09 |
| P/B (TTM) | 0.10 |
| P/S (TTM) | 184.30 |
| Earnings Date | n/a |
| Precio de venta | 1.23 |
| Volumen | 352,233 |
| Volumen medio (20D) | 2,717,283 |
| Abierto | 1.07 |
| Anterior Cerrar | 1.20 |
| Rango del día | 0.96 - 1.08 |
| Rango de 52 semanas | 0.95 - 17.95 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de PRFX
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known...
Industria Drug Manufacturers - Specialty & Generic
Sector Healthcare
IPO Fecha Sep 1, 2020
Empleados 6
Bolsa de Valores NasdaqCM
Símbolo bursátil PRFX
Sitio web https://www.painreform.com
Desempeño financiero
En 2025, los ingresos de PRF fueron 17K, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -5.02M, una disminución de -65.57%.
Estados financierosSorpresa de resultados
PRF ha publicado sus resultados trimestrales en Aug 15, 2024:
